Erythrocyte creatine as a marker of intravascular hemolysis due to left ventricular outflow tract obstruction in hypertrophic cardiomyopathy

详细信息    查看全文

• 作者：Toru Kubo ; MD ; PhD ; FJCC^a ; ^{jm-kubotoru@kochi-u.ac.jp" class="auth_mail" title="E-mail the corresponding author} ; Toshika Okumiya ; PhD^b ; Yuichi Baba ; MD ; PhD^a ; Takayoshi Hirota ; MD ; PhD^a ; Katsutoshi Tanioka ; MD^a ; Naohito Yamasaki ; MD ; PhD^a ; Tetsuro Sugiura ; MD ; PhD ; FJCC^c ; Yoshinori L. Doi ; MD ; PhD ; FJCC^a ; Hiroaki Kitaoka ; MD ; PhD ; FJCC^a
• 关键词：Hypertrophic cardiomyopathy ; Biomarker ; Erythrocyte creatine ; Hemolysis ; Left ventricular outflow tract obstruction
• 刊名：Journal of Cardiology
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：67
• 期：3
• 页码：274-278
• 全文大小：517 K

文摘

Erythrocyte creatine, a marker of erythrocyte age that increases with shortening of erythrocyte survival, has been reported to be a quantitative and reliable marker for intravascular hemolysis. We hypothesized that hemolysis could also occur due to intraventricular obstruction in patients with hypertrophic cardiomyopathy (HCM). The purpose of this study was to examine the presence of subclinical hemolysis and the relation between intravascular hemolysis and intraventricular pressure gradient (IVPG).

Methods and results

We measured erythrocyte creatine in 92 HCM patients. Twelve patients had left ventricular outflow tract obstruction (LVOTO), 4 had midventricular obstruction (MVO), and the remaining 76 were non-obstructive. Erythrocyte creatine levels ranged from 0.92 to 4.36 μmol/g hemoglobin. Higher levels of erythrocyte creatine were associated with higher IVPG (r = 0.437, p < 0.001). If erythrocyte creatine levels are high (≥1.8 μmol/g hemoglobin), subclinical hemolysis is considered to be present. Half of LVOTO patients and no MVO patients showed high erythrocyte creatine levels. Although non-obstructive patients did not show significant intraventricular obstruction at rest, some showed high erythrocyte creatine levels. When LVOT-PG was measured during the strain phase of the Valsalva maneuver in 20 non-obstructive patients, 7 of those 20 patients showed LVOTO. In the 20 patients, there was no relation between erythrocyte creatine levels and LVOT-PG before the Valsalva maneuver (r = 0.125, p = 0.600), whereas there was a significant correlation between erythrocyte creatine and LVOT-PG provoked by the Valsalva maneuver (r = 0.695, p = 0.001).

Conclusions

There is biochemical evidence of subclinical hemolysis in patients with HCM, and this hemolysis seems to be associated with LVOTO provoked by daily physical activities.